Skip to main content

Table 1 Schedule of enrollment, interventions, and examinations

From: Angiotensin-converting enzyme inhibitor for post-transcatheter aortic valve implantation patients: study protocol for a multicenter randomized, open-label blinded endpoint control trial

Time point

Study period

Enrolment

Allocation

Post-allocation

1 week pre

0

1 month

3 months

6 months

12 months

24 months

Enrollment

 Eligibility screen

X

      

 Informed consent

X

      

 Allocation

 

X

     

Interventions

 Standard care

  

X

X

X

X

X

 Standard care plus fosinopril

  

X

X

X

X

X

Assessments

 Demographics

X

      

 Physical examinations

X

 

X

X

X

X

X

 Medical history

X

 

X

X

X

X

X

 Laboratory tests

X

 

X

X

X

X

X

 NYHA class

X

 

X

X

X

X

X

 Transthoracic echocardiography

X

 

X

X

X

X

X

 CMR

 

X

    

X

 KCCQ

 

X

X

X

X

X

X

 6-min walk test

 

X

X

X

X

X

X

 Adverse events

  

X

X

X

X

X

  1. NYHA New York Heart Association, CMR cardiac magnetic resonance, KCCQ Kansas City Cardiomyopathy Questionnaire
Back to article page

Trials

ISSN: 1745-6215